Journal article
Reversal of Anisocoria in Horner Syndrome Following Commencement of Oral Reboxetine, a Selective Norepinephrine Reuptake Inhibitor
Journal of neuro-ophthalmology, Vol.44(2), pp.e261-e262
06/2024
DOI: 10.1097/WNO.0000000000001814
PMID: 36857129
Abstract
Clinical Correspondence
Details
- Title: Subtitle
- Reversal of Anisocoria in Horner Syndrome Following Commencement of Oral Reboxetine, a Selective Norepinephrine Reuptake Inhibitor
- Creators
- Blake D Colman - Department of Neuroscience (BDC), Central Clinical School, Faculty of Medicine, Nursing and Health Science, Monash University, Melbourne, Victoria, Australia; Department of Neurology (BDC), Alfred Hospital, Melbourne, Victoria, Australia; Department of Neurology (BDC, AF), Royal Melbourne Hospital, Melbourne, Victoria, Australia; Department of Neuro-Ophthalmology (BDC, AF), Royal Victorian Eye and Ear Hospital, Melbourne, Victoria, Australia; and Department of Ophthalmology and Visual Sciences (RHK), Neuro-Ophthalmology Division, University of Iowa, Iowa City, Iowa.Anthony J FokRandy H Kardon
- Resource Type
- Journal article
- Publication Details
- Journal of neuro-ophthalmology, Vol.44(2), pp.e261-e262
- DOI
- 10.1097/WNO.0000000000001814
- PMID
- 36857129
- NLM abbreviation
- J Neuroophthalmol
- eISSN
- 1536-5166
- Language
- English
- Electronic publication date
- 03/01/2023
- Date published
- 06/2024
- Academic Unit
- Iowa Neuroscience Institute; Ophthalmology and Visual Sciences
- Record Identifier
- 9984375353002771
Metrics
17 Record Views